Eye Diseases, Hereditary Trials

Eye Diseases, Hereditary	Welcome, Profile Billing Logout

Eye Diseases, Hereditary

Welcome, Profile Billing Logout

35 Companies

28 Products

37 Mechanisms of Action

2 Trials

230 News

2 Trials

Active Trials

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Eye Diseases, Hereditary

NCT02465749: Clinical Trials of Continuous Oxygen Therapy Combined With Blue Light Deprivation in the Treatment of Retinitis Pigmentosa

Not yet recruiting

404

RoW

Continuous oxygen, blue light-absorbing sunglasses, Compound thrombosis capsule sig: 1.5g/tid, Ginkgo biloba pills sig: 300mg/tid;, Vitamin B sig: 10mg/tid, Vitamin AD sig: 1 tablet/tid

Sun Yat-sen University, Zhujiang Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou Jeeyor Medical Research Co.,Ltd.

Retinitis Pigmentosa

06/25

NCT02300753: Emergency Administration of EPI-743 to a Single Patient With Leber's Hereditary Optic Neuropathy [LHON]

No Longer Available

N/A

EPI-743, Vincerinone (TM), Vatiquinone

Edison Pharmaceuticals Inc

Leber's Hereditary Optic Neuropathy